38 results
424B3
TSHA
Taysha Gene Therapies Inc
11 Sep 23
Prospectus supplement
4:01pm
with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor’s report on financial
424B3
agrw9ouwv7bn1
4 May 23
Prospectus supplement
4:02pm
PRE 14A
l7ig6124qcc7rcigh
27 Apr 23
Preliminary proxy
4:03pm
8-K/A
EX-10.2
kv8amqus9s2wzwz yudx
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
8-K
EX-1.1
st5mrktk p6
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm
424B5
yjwyr
27 Oct 22
Prospectus supplement for primary offering
5:13pm
424B5
qezatui i6dy
25 Oct 22
Prospectus supplement for primary offering
4:35pm